These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15668009

  • 1. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli.
    Hu Y, Coates AR.
    FEMS Microbiol Lett; 2005 Feb 01; 243(1):117-24. PubMed ID: 15668009
    [Abstract] [Full Text] [Related]

  • 2. Identifying Escherichia coli genes involved in intrinsic multidrug resistance.
    Duo M, Hou S, Ren D.
    Appl Microbiol Biotechnol; 2008 Dec 01; 81(4):731-41. PubMed ID: 18807027
    [Abstract] [Full Text] [Related]

  • 3. Systematic identification of genetic loci required for polymyxin resistance in Campylobacter jejuni using an efficient in vivo transposon mutagenesis system.
    Lin J, Wang Y, Hoang KV.
    Foodborne Pathog Dis; 2009 Mar 01; 6(2):173-185. PubMed ID: 19105633
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic and genotypic characterization of antimicrobial resistance in Escherichia coli O111 isolates.
    Guerra B, Junker E, Schroeter A, Helmuth R, Guth BE, Beutin L.
    J Antimicrob Chemother; 2006 Jun 01; 57(6):1210-4. PubMed ID: 16603644
    [Abstract] [Full Text] [Related]

  • 5. Whole-genome detection of conditionally essential and dispensable genes in Escherichia coli via genetic footprinting.
    Scholle MD, Gerdes SY.
    Methods Mol Biol; 2008 Jun 01; 416():83-102. PubMed ID: 18392962
    [Abstract] [Full Text] [Related]

  • 6. Characterization of HEp-2 cell projection formation induced by diffusely adherent Escherichia coli.
    Cookson ST, Nataro JP.
    Microb Pathog; 1996 Dec 01; 21(6):421-34. PubMed ID: 8971683
    [Abstract] [Full Text] [Related]

  • 7. GlpD and PlsB participate in persister cell formation in Escherichia coli.
    Spoering AL, Vulic M, Lewis K.
    J Bacteriol; 2006 Jul 01; 188(14):5136-44. PubMed ID: 16816185
    [Abstract] [Full Text] [Related]

  • 8. Use of a novel allele of the Escherichia coli aacC4 aminoglycoside resistance gene as a genetic marker in mycobacteria.
    Consaul SA, Pavelka MS.
    FEMS Microbiol Lett; 2004 May 15; 234(2):297-301. PubMed ID: 15135536
    [Abstract] [Full Text] [Related]

  • 9. Analysis of integrons in clinical isolates of Escherichia coli in China during the last six years.
    Su J, Shi L, Yang L, Xiao Z, Li X, Yamasaki S.
    FEMS Microbiol Lett; 2006 Jan 15; 254(1):75-80. PubMed ID: 16451182
    [Abstract] [Full Text] [Related]

  • 10. Effects of the twin-arginine translocase on the structure and antimicrobial susceptibility of Escherichia coli biofilms.
    Harrison JJ, Ceri H, Badry EA, Roper NJ, Tomlin KL, Turner RJ.
    Can J Microbiol; 2005 Aug 15; 51(8):671-83. PubMed ID: 16234865
    [Abstract] [Full Text] [Related]

  • 11. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L, Lindqvist A, Kahlmeter G, Andersson DI.
    J Antimicrob Chemother; 2008 Sep 15; 62(3):495-503. PubMed ID: 18544599
    [Abstract] [Full Text] [Related]

  • 12. A profile of drug resistance genes and integrons in E. coli causing surgical wound infections in the Faisalabad region of Pakistan.
    Saeed MA, Haque A, Ali A, Mohsin M, Bashir S, Tariq A, Afzal A, Iftikhar T, Sarwar Y.
    J Antibiot (Tokyo); 2009 Jun 15; 62(6):319-23. PubMed ID: 19444298
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
    Usein CR, Tatu-Chiţoiu D, Nica M, Ciontea SA, Palade AM, Condei M, Damian M.
    Roum Arch Microbiol Immunol; 2008 Jun 15; 67(1-2):23-9. PubMed ID: 19284163
    [Abstract] [Full Text] [Related]

  • 14. The outer membrane TolC is involved in cysteine tolerance and overproduction in Escherichia coli.
    Wiriyathanawudhiwong N, Ohtsu I, Li ZD, Mori H, Takagi H.
    Appl Microbiol Biotechnol; 2009 Jan 15; 81(5):903-13. PubMed ID: 18828007
    [Abstract] [Full Text] [Related]

  • 15. Multidrug resistant enteroaggregative Escherichia coli diarrhoea in rural southern Indian population.
    Raju B, Ballal M.
    Scand J Infect Dis; 2009 Jan 15; 41(2):105-8. PubMed ID: 19107675
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD, Le P, Church DL, Gregson DB, Laupland KB.
    Int J Antimicrob Agents; 2008 Oct 15; 32(4):333-8. PubMed ID: 18701262
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A, Blanco JE, Blanco M, Alonso MP, Dhabi G, Echeita A, González EA, Bernárdez MI, Blanco J.
    Res Microbiol; 2005 Aug 15; 156(7):793-806. PubMed ID: 15921895
    [Abstract] [Full Text] [Related]

  • 18. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA, Schuster S, Fähnrich E, Trittler R, Kern WV.
    J Antimicrob Chemother; 2007 Jun 15; 59(6):1216-22. PubMed ID: 17062614
    [Abstract] [Full Text] [Related]

  • 19. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.
    Tan XX, Actor JK, Chen Y.
    Antimicrob Agents Chemother; 2005 Aug 15; 49(8):3203-7. PubMed ID: 16048926
    [Abstract] [Full Text] [Related]

  • 20. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP, Manges AR, Riley LW.
    Clin Infect Dis; 2008 Mar 01; 46(5):689-95. PubMed ID: 18230040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.